about
The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults.Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patientsParametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET ScannerA multistudy analysis of the effects of early cocaine abstinence on sleepThe effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adultsImaging robust microglial activation after lipopolysaccharide administration in humans with PET.A single-day paradigm of self-regulated human cocaine administration.Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals.Prefrontal cortical response to emotional faces in individuals with major depressive disorder in remission.Elevated Dopamine D2/3 Receptor Availability in Obese Individuals: A PET Imaging Study with [11C](+)PHNO.Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression.A case series on the heightened autonomic response due to guanfacine and amphetamine interaction.Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences.The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET Study.Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder.Kinetic evaluation and test-retest reproducibility of [(11)C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence.Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.Evaluation of (-)-[18 F]Flubatine-specific binding: Implications for reference region approaches.Memory reconsolidation for treatment-resistant aggression and self-injurious behaviors.Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder.Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.Imaging synaptic density in the living human brain.Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with 11C-GSK215083 PET.Editorial: PET Imaging in NeuroscienceMetabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging StudyLower synaptic density is associated with depression severity and network alterationsFurther in vivo characterization of [11 C]-(+)-PHNO uptake into a retina-like region of interest in humansKinetic modeling and test-retest reproducibility of 11C-EKAP and 11C-FEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humansReproducibility of the correlative triad among aging, dopamine receptor availability, and cognitionPET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseasesPositron emission tomography imaging of the γ-aminobutyric acid systemBinge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine releaseClinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demiseMeasuring the effects of ketamine on mGluR5 using [18F]FPEB and PETIn vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PETKappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography studySex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokersIn vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideationEffects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study
P50
Q33929815-FD0131C1-AB06-48E9-A0CF-6692D193D396Q34069808-C15BED07-948B-4C43-8BB1-A73E4C4B2312Q34362666-376C85D0-CDEE-4A63-BE38-887B1DF2FB78Q34851016-4A79BB17-EE0A-452F-90C5-6C8D4020D4E5Q35864146-E77D0543-64A9-4034-A6AF-6FA3D560304EQ36155325-CA6058C4-7BAF-4213-A734-9650EF7D5C68Q36838778-8ED34BB3-2191-4444-AA99-16FEC0CD41F0Q37262765-2D6EE142-E222-4690-A62D-1F73CD711B6FQ37716174-6AEF7FAC-3FA2-4C89-AF2B-028ECB158502Q39635324-B2F7400E-6714-4E5B-8606-0B366D121808Q41994846-C85643FE-6191-4216-B8C1-9898C1B2AC56Q43167283-CD5DFE0F-D8B9-4B5C-916E-671FEC6C43D0Q47392942-E9FDB76B-8943-4FD2-BD91-BA751D9EF99FQ47637653-739A61DD-7A59-4135-A4D4-BAEC8336A1F0Q47759379-1AFE42D6-EBD3-43E0-AC64-873022819EAEQ47814823-2C39AD57-6AB4-4D01-9242-3798E94EAD0CQ47823561-AD5BBBF4-819E-410B-96C7-040C0590B543Q47900809-112858F4-5AEA-4131-AEE2-3941E694788AQ47985846-800945EB-1DAC-4582-AC2F-1073B0EBAC34Q48153120-DAA54902-6652-474B-88C3-E2BE7522C0EDQ48346301-BF259EC8-B2B1-47D5-9BF3-73F08AD14E20Q48446191-D3E49E98-6705-4E12-8530-7CF7606CCB36Q48613124-1922C61E-5E4B-48D1-81F9-7427CA371817Q52601676-9B749844-C98D-4704-9232-C5F025CEF17BQ57813818-262EB274-EF31-4A3F-A5B4-CD701EFB9F16Q58213887-C2630485-6E46-44AD-A03C-8388BE2FB0FCQ64077366-A25C070F-9EEC-4962-ABD8-34B075A1F9ECQ90280838-2B13A2DA-B11C-4CAA-AD11-3C4BD3776684Q90315396-1E9265B7-A905-4896-906A-4B5BE9A3B8A7Q90552268-23AB6633-0087-477C-8F2E-BF4E74C7168EQ90741360-793A8465-4284-45E3-9A8C-9BD5E85064F9Q90918752-4E1B29BF-6804-4340-8359-35A239B4EA7EQ91028765-510B30DF-C321-43AA-92EC-6DABCFF15716Q91240169-EBB45977-E399-436B-AEEE-31D41DEBFFCFQ91342215-41E2AAD9-43BF-47DF-9714-1B4C7865F823Q91416244-24F30181-194E-4E92-8969-F3D0CE427CD5Q91546842-61A5DFA1-6751-4D19-9F28-CD8628BDBEDBQ91586672-E5DDB849-9DE0-47BB-AEB0-4DA8337643BCQ91996058-DD969F02-657E-4EC4-878F-50E553C6CDE4Q92301042-F1DA9D41-3536-488C-97C0-4D372204159C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Matuskey
@ast
David Matuskey
@en
David Matuskey
@es
David Matuskey
@nl
type
label
David Matuskey
@ast
David Matuskey
@en
David Matuskey
@es
David Matuskey
@nl
prefLabel
David Matuskey
@ast
David Matuskey
@en
David Matuskey
@es
David Matuskey
@nl
P106
P1153
36458857700
P21
P31
P496
0000-0001-7508-6572